Houston Rx LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • No warning letters matched by name
Inspections 0 0 OAI
Recalls 2 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Houston Rx LLC has 2 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Houston Rx LLC" is on file. FDA has published 1 Form 483 for Houston Rx LLC.

What these totals cover: FDA records filed under the name "Houston Rx LLC" and its spelling variant "Houston Rx".

Latest recall
D-0041-2027 · Class II · Sep 25, 2026

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls2Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections0Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Houston Rx LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Houston Rx LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Houston Rx LLC Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Aug 28, 2026 · Document on fda.gov 4833045022201

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

2 recall records on Sep 25, 2026.

NumberClassProductDate
D-0041-2027Class IISermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage…Sep 25, 2026
D-0040-2027Class IITirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430…Sep 25, 2026

Houston Rx LLC and the FDA: common questions

Has Houston Rx LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Houston Rx LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Houston Rx LLC received an FDA Form 483?

FDA has published 1 Form 483 for Houston Rx LLC in its reading room, the most recent dated Aug 28, 2026. FDA publishes some Form 483s, not all of them.

Has Houston Rx LLC had an FDA recall?

Yes. Houston Rx LLC has 2 FDA recalls on record. The most recent started Sep 25, 2026.

Need more than this page shows? Ask about Houston Rx LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.